KITE , A GILEAD COMPANY
WATCH NOW
QUALIFICATION OF A ONE-TIME TREATMENT
What exactly does a one-time treatment look like ? At what point can clinicians declare success ?
Perettie addresses this , explaining the criteria for a successful one-time case study . In the oncology field , if a patient survives five years or more beyond their treatment with no need for additional cancer treatment , this can be suggestive of a potential cure .
and quality , reliability , and speed are critical . From the early stages of manufacturing to logistical aspects of treatment delivery , Kite strives for operational excellence , leveraging technologies to make their rapid and reliable turnaround time and 96 % manufacturing success rate possible . Following the recent FDA approval of a shorter manufacturing time for certain CAR T therapies in the US , the organisation is anticipating reducing its already industry-leading turnaround time from 16 days to 14 in the U . S . This has a realworld impact for patients as two days in the life of a patient with an aggressive disease can be too long to wait .
The organisation now has two approved therapies available for use in five different indications .
56 March 2024